Delivery Order SPE2DB20D3103-SPE2DB25FN7Y2

Award Date 5/13/25
Potential Completion Date 6/4/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,726.08, is for the delivery of Calquence 100 mg tablets over a period ending on November 22, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $84,720.33 firm-fixed-price delivery order is for the supply of 4560341607 Calquence 100 mg Tablet 60s. The contract has an ultimate completion date of April 12, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $11,187.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,568,174,728 units of the medication CALQUENCE 100 MG TABLET 60S. The contract has a firm fixed price and an ultimate completion date of May 29, 2025. This award is not associated with any set-aside program and is an open competition contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,575.36 firm fixed-price delivery order is for the supply of 4565067241 Calquence 100 mg tablets, with a period of performance through July 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,593.77 fixed-price delivery order is for the supply of Calquence 100 mg tablets to support federal medical procurement needs. The contract has a performance period through May 28, 2025 and is not designated as a set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,781.31 firm fixed-price delivery order is for the supply of Calquence 100 mg tablets, a medication used to treat a certain type of leukemia. The contract has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $5,593.77 for the supply of Calquence 100 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 7, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. In addition to this Delivery Order, Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,743.48 firm-fixed-price delivery order is for the supply of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company that serves as a prime contractor to the U.S. government. The contract, valued at $25,726.08, is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of the prescription drug Calquence in 60-count tablet bottles. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,150.74 firm fixed-price contract is for the delivery of the brand-name medication CALQUENCE 100 MG TABLET 60S, with a completion date of November 27, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN7Y2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,187.56 firm-fixed-price delivery order is for the supply of 4,568,232,872 units of the medication Calquence 100 mg tablets. The award has a performance period extending through June 4, 2025.

AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award discussed is not designated as a set-aside.

Generated 8/12/25, 12:19 PM